Fresenius kabi great britain was informed of a serious adverse event (sae) that occurred in april.The national health service blood and transplant (nhsbt) birmingham plasma donor center was notified that a few days after donation, a donor presented in hospital with bilateral pulmonary embolism.There is no suggestion that the donation is part of the root cause but as part of nhsbt investigation they are looking at all possible causes.The donor contacted customer services to report that they had been diagnosed with bilateral pulmonary embolism 11 days post pfm donation.The donor advised cst they were admitted to hospital (b)(6) 2023 after symptoms of shortness of breath and chest pain.They (donor) have since found some research papers that may suggest increased risk of blood clots from plasma donation.The donor's discharge summary from hospital, sent to cst (b)(6) 2023, documented that donor had been feeling generally unwell for 4 weeks prior to admission to hospital.D/w donor medical team and lead nurse cst advised to raise as sae.The donor donated at least once a month and on some occasions twice monthly.His last donations were on (b)(6) 2023.He is a (b)(6) male.Nothing regarding the donor being unwell was noted on his donor safety check (dsc) and his donor primary nurse (dpn) stated that there were no issues during his donations.No sample or picture were received by fresenius kabi for evaluation.Therefore, no potential root cause of the event could be identified.A batch review was completed for material 6r2281, batch fa21l01058.No exceptions were generated that could classify as a possible root cause of this event.Fresenius kabi usa made three attempts for additional information, including the device's logfiles, with no response as of the day of this report.There is no indication that any adverse event occurred during the previous or most recent donation, nor has any issue with the device been reported.
|